Chai Discovery raises $400 million for AI drug discovery

Axios Pro Rata's July 14 venture roundup says Chai Discovery raised $400 million for AI drug discovery. The round lands in a year when investors are still backing large life-sciences AI platforms, even as the broader AI market faces questions about infrastructure costs and eventual returns. The financing puts Chai Discovery among the better-funded current AI biology companies.

Key details: Chai Discovery raised $400 million, The company works in AI drug discovery, The round was highlighted in Axios Pro Rata's July 14 venture roundup.

Why it matters: Large AI-biology rounds show investors are still willing to fund expensive scientific platforms, not just enterprise copilots or consumer agents.